The stock market’s previous breakneck pace is slowing down. Here’s what investors can expect next.

• President Trump is losing the stock market war to the rest of the world so far. Here's where investors are taking advantage

  Emerging market stocks, China and European stocks are beating U.S. indexes since the inauguration of Donald Trump.
  
  CNBC - 4h

• This stock sector can still soar during the late stages of the bull market — and there are easy ways to play it

  Also: Nvidia earnings on deck, potential stock splits and big gains, a look at gold, and the Moneyist pulls no punches.
  
  MarketWatch - 3h
• 

  The name’s Bezos, Jeff Bezos: what can we expect from Amazon’s James Bond?

  With one of the film industry’s most lucrative franchises signed over to Amazon MGM, 007 could be facing down the barrel of spin-offs, quasi-crowdsourcing and a cinematic universe to rival Marvel. ...
  
  The Guardian - 5h

• Investors call for shake-up of Europe’s ‘failed’ securitisation market

  Fund managers and insurers say long-overdue reforms could unlock hundreds of billions of euros in financing
  
  Financial Times - 14h

• What might an optimistic investor buy in the UK?

  The outlook is far from rosy, but what if we’re overdoing the doom and gloom?
  
  Financial Times - 8h

• Your retirement savings are at risk in an insane stock market

  Fund managers admit they’re buying overvalued stocks.
  
  MarketWatch - 13m
• 

  Move over H5N1: The next pandemic is already here

  The widespread use of antibiotics in industrial animal agriculture is contributing to the rise of antibiotic resistance, with over 35,000 Americans expected to die this year from a preventable ...
  
  The Hill - 1h

• Jim Cramer says our newest stock is a buy after dipping on slow start to 2025

  The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
  
  CNBC - 2h

• The stock market is trying to break out — but the bulls can’t catch a break

  S&P 500 is stuck in a trading range.
  
  MarketWatch - 17h

• Tech stocks seem to have ended their ‘difficult relationship’ with the bond market

  At least for now, U.S. large-cap technology and growth stocks appear “free of their difficult relationship with long-term yields,” according to DataTrek Research.
  
  MarketWatch - 16h

More from MarketWatch

• Your retirement savings are at risk in an insane stock market

  Fund managers admit they’re buying overvalued stocks.
  
  MarketWatch - 13m

• Celsius wants to sell more energy drinks to women. Wall Street likes the move.

  Celsius shares are up more than 30% after its quarterly results topped estimates and it announced plans to buy drink maker Alani Nu.
  
  MarketWatch - 24m

• Walmart’s stock continues to drop despite ‘near-term buying opportunity’

  Walmart Inc.’s stock deepened its losses on Friday after a brutal selloff in the previous session, as investors brushed aside positive comments from analysts.
  
  MarketWatch - 36m

• Generation X is ready for senior living. Here’s what they want.

  Retirement communities are courting members of Gen X, who will outnumber baby boomers in 2028.
  
  MarketWatch - 41m

• Crypto exchange Bybit suffers $1.4 billion hack. Here’s why it’s troubling for the industry.

  The hack of Bybit is the latest incident in which the crypto industry has been targeted.
  
  MarketWatch - 44m

More in Business

• Your retirement savings are at risk in an insane stock market

  Fund managers admit they’re buying overvalued stocks.
  
  MarketWatch - 13m

• Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

  The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
  
  CNBC - 16m

• Celsius wants to sell more energy drinks to women. Wall Street likes the move.

  Celsius shares are up more than 30% after its quarterly results topped estimates and it announced plans to buy drink maker Alani Nu.
  
  MarketWatch - 24m
• 

  Firings at FDA Decimated Teams Reviewing AI and Food Safety

  Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though industry fees, not taxpayers, financed the employee salaries.
  
  The New York Times - 25m
• 

  Firings at FDA Decimated Teams Reviewing AI and Food Safety

  Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though industry fees, not taxpayers, financed the employee salaries.
  
  The New York Times - 25m